Quantum Healthcare Limited (SGX:V8Y)
Singapore
· Delayed Price · Currency is SGD 0.0010
-0.0010 (-50.00%)
At close: Jun 17, 2025
Quantum Healthcare Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 12.86 | 12.69 | 13.08 | 9.37 | - | 0.74 | Upgrade
|
| Revenue Growth (YoY) | -0.26% | -3.03% | 39.63% | - | - | -93.12% | Upgrade
|
| Cost of Revenue | 7.05 | 7.03 | 7.32 | 5.02 | - | 0.81 | Upgrade
|
| Gross Profit | 5.81 | 5.66 | 5.76 | 4.35 | - | -0.08 | Upgrade
|
| Selling, General & Admin | 6.64 | 6.89 | 8.73 | 6.61 | 3.26 | 4.54 | Upgrade
|
| Research & Development | - | - | - | 0.74 | - | 5.32 | Upgrade
|
| Other Operating Expenses | -0.14 | -0.16 | -0.18 | -0.09 | 0 | -0.52 | Upgrade
|
| Operating Expenses | 6.5 | 6.73 | 8.55 | 7.27 | 3.26 | 9.34 | Upgrade
|
| Operating Income | -0.69 | -1.08 | -2.79 | -2.92 | -3.26 | -9.42 | Upgrade
|
| Interest Expense | -0.46 | -0.46 | -0.49 | -0.45 | -0.03 | -0.36 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | -0 | -0.04 | -0.04 | Upgrade
|
| EBT Excluding Unusual Items | -1.15 | -1.54 | -3.28 | -3.37 | -3.34 | -9.82 | Upgrade
|
| Impairment of Goodwill | -1.01 | -1.01 | - | -4.63 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.02 | 0.02 | - | -0.79 | 0.14 | -0.19 | Upgrade
|
| Asset Writedown | - | - | - | - | -2.11 | -0.01 | Upgrade
|
| Pretax Income | -2.14 | -2.52 | -3.28 | -8.78 | -5.31 | -10.01 | Upgrade
|
| Income Tax Expense | 0.04 | 0.04 | 0.1 | 0.12 | - | 0 | Upgrade
|
| Earnings From Continuing Operations | -2.18 | -2.56 | -3.38 | -8.9 | -5.31 | -10.02 | Upgrade
|
| Minority Interest in Earnings | 0.34 | 0.33 | -0.24 | -0.17 | 0.03 | - | Upgrade
|
| Net Income | -1.84 | -2.23 | -3.62 | -9.07 | -5.28 | -10.02 | Upgrade
|
| Net Income to Common | -1.84 | -2.23 | -3.62 | -9.07 | -5.28 | -10.02 | Upgrade
|
| Shares Outstanding (Basic) | 7,947 | 7,947 | 7,327 | 6,751 | 2,260 | 2,171 | Upgrade
|
| Shares Outstanding (Diluted) | 7,947 | 7,947 | 7,327 | 6,751 | 2,260 | 2,171 | Upgrade
|
| Shares Change (YoY) | 5.49% | 8.46% | 8.53% | 198.73% | 4.08% | - | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Free Cash Flow | 0.77 | 1.1 | -0.93 | -2.23 | -1.3 | -7.92 | Upgrade
|
| Free Cash Flow Per Share | - | - | - | - | -0.00 | -0.00 | Upgrade
|
| Gross Margin | 45.16% | 44.60% | 44.03% | 46.42% | - | -10.59% | Upgrade
|
| Operating Margin | -5.40% | -8.48% | -21.34% | -31.14% | - | -1279.53% | Upgrade
|
| Profit Margin | -14.32% | -17.61% | -27.68% | -96.78% | - | -1360.32% | Upgrade
|
| Free Cash Flow Margin | 6.00% | 8.63% | -7.08% | -23.76% | - | -1076.30% | Upgrade
|
| EBITDA | -0.28 | -0.56 | -2.31 | -2.59 | -3.17 | -9.33 | Upgrade
|
| EBITDA Margin | -2.17% | -4.38% | -17.68% | -27.62% | - | - | Upgrade
|
| D&A For EBITDA | 0.42 | 0.52 | 0.48 | 0.33 | 0.09 | 0.09 | Upgrade
|
| EBIT | -0.69 | -1.08 | -2.79 | -2.92 | -3.26 | -9.42 | Upgrade
|
| EBIT Margin | -5.40% | -8.48% | -21.34% | -31.14% | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.